New Organometallic Tetraphenylethylene⋅Iridium(III) Complexes with Antineoplastic Activity

Area of Science:

• Inorganic Chemistry
• Medicinal Chemistry
• Cancer Therapeutics

Background:

• Iridium(III) complexes are gaining attention for their potential anticancer properties.
• Developing novel antineoplastic agents is crucial for cancer treatment.

Purpose of the Study:

• To synthesize and characterize novel iridium(III) complexes.
• To evaluate their antineoplastic activity and mechanisms of action against A549 cancer cells.

Main Methods:

• Synthesis and characterization of four iridium(III) complexes.
• In vitro evaluation of cytotoxicity against A549 cells and normal cells.
• Investigation of serum albumin binding, enzymatic catalysis, reactive oxygen species generation, lysosomal targeting, and apoptosis induction.

Main Results:

• Complex 1 exhibited significant antineoplastic activity (IC50 = 3.56 ± 0.5 μm), exceeding cisplatin's efficacy.
• The complexes demonstrated selectivity towards cancer cells over normal cells.
• Complexes 1 and 2 induced oxidative stress via NADH oxidation, while complexes 3 and 4 targeted lysosomes, causing damage and apoptosis.

Conclusions:

• The synthesized iridium(III) complexes possess promising antineoplastic potential.
• Distinct mechanisms of action, including oxidative stress and lysosomal disruption, contribute to their efficacy.
• Further optimization of these complexes could lead to novel cancer therapeutics.